News
COMUNICADO: Micromedic publica los resultados de un estudio clínico...
www.europapress.es
-- Planea asegurar la marca CE para un lanzamiento europeo de la prueba no invasiva y presentar una pre -IDE...
Erfolgsergebnisse bei klinischer Studie zur Beobachtung des...
www.krebs-nachrichten.de
Kontakt: Micromedic, Steven Eitan, CEO, Tel.: + , . Veröffentlichung: Letzte Änderung: , 12:21 | tsc.
Exalenz Bioscience signs two US distribution deals: The GI...
insurancenewsnet.com
Exalenz CEO Steven Eitan said, "We're proud to complete our nationwide distribution network in the US, which will promote the sale of our ...
Exalenz Unveils BreathID For Point-of-Care Detection Of H Pylori - NS...
www.nsmedicaldevices.com
Steven Eitan, CEO of Exalenz, said: “The BreathID is an exciting solution, enabling physicians to offer excellent care to patients. Its ability to ...
sortiert nach Relevanz / Datum